RT Journal Article
T1 Advancing the global public health agenda for NAFLD: a consensus statement.
A1 Lazarus, Jeffrey V
A1 Mark, Henry E
A1 Anstee, Quentin M
A1 Arab, Juan Pablo
A1 Batterham, Rachel L
A1 Castera, Laurent
A1 Cortez-Pinto, Helena
A1 Crespo, Javier
A1 Cusi, Kenneth
A1 Dirac, M Ashworth
A1 Francque, Sven
A1 George, Jacob
A1 Hagström, Hannes
A1 Huang, Terry T-K
A1 Ismail, Mona H
A1 Kautz, Achim
A1 Sarin, Shiv Kumar
A1 Loomba, Rohit
A1 Miller, Veronica
A1 Newsome, Philip N
A1 Ninburg, Michael
A1 Ocama, Ponsiano
A1 Ratziu, Vlad
A1 Rinella, Mary
A1 Romero, Diana
A1 Romero-Gómez, Manuel
A1 Schattenberg, Jörn M
A1 Tsochatzis, Emmanuel A
A1 Valenti, Luca
A1 Wong, Vincent Wai-Sun
A1 Yilmaz, Yusuf
A1 Younossi, Zobair M
A1 Zelber-Sagi, Shira
A1 NAFLD Consensus Consortium, 
AB Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It is a multisystem disease and is considered the hepatic component of metabolic syndrome. Unlike other highly prevalent conditions, NAFLD has received little attention from the global public health community. Health system and public health responses to NAFLD have been weak and fragmented, and, despite its pervasiveness, NAFLD is largely unknown outside hepatology and gastroenterology. There is only a nascent global public health movement addressing NAFLD, and the disease is absent from nearly all national and international strategies and policies for non-communicable diseases, including obesity. In this global Delphi study, a multidisciplinary group of experts developed consensus statements and recommendations, which a larger group of collaborators reviewed over three rounds until consensus was achieved. The resulting consensus statements and recommendations address a broad range of topics - from epidemiology, awareness, care and treatment to public health policies and leadership - that have general relevance for policy-makers, health-care practitioners, civil society groups, research institutions and affected populations. These recommendations should provide a strong foundation for a comprehensive public health response to NAFLD.
YR 2021
FD 2021-10-27
LK http://hdl.handle.net/10668/19566
UL http://hdl.handle.net/10668/19566
LA en
DS RISalud
RD Apr 14, 2025